Free Trial

Chemed Co. (NYSE:CHE) CEO Sells $864,675.00 in Stock

Chemed logo with Medical background

Chemed Co. (NYSE:CHE - Get Free Report) CEO Kevin J. Mcnamara sold 1,500 shares of the firm's stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $576.45, for a total transaction of $864,675.00. Following the sale, the chief executive officer now directly owns 101,197 shares in the company, valued at approximately $58,335,010.65. The trade was a 1.46 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Chemed Trading Down 0.1 %

Shares of Chemed stock traded down $0.47 during trading on Tuesday, reaching $575.61. The company's stock had a trading volume of 55,048 shares, compared to its average volume of 99,617. The firm has a market cap of $8.42 billion, a PE ratio of 29.09, a P/E/G ratio of 2.15 and a beta of 0.59. The company has a 50-day moving average price of $590.61 and a two-hundred day moving average price of $565.49. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business had revenue of $646.94 million during the quarter, compared to analysts' expectations of $641.78 million. During the same period in the prior year, the company earned $5.20 earnings per share. The business's revenue was up 9.8% compared to the same quarter last year. On average, analysts predict that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were paid a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. Chemed's dividend payout ratio (DPR) is currently 9.74%.

Wall Street Analyst Weigh In

CHE has been the subject of a number of research reports. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada boosted their target price on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a report on Monday, April 28th.

Check Out Our Latest Stock Report on CHE

Institutional Investors Weigh In On Chemed

Several large investors have recently modified their holdings of the stock. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Chemed in the 1st quarter valued at $4,670,000. Wealth Alliance LLC boosted its holdings in shares of Chemed by 5.4% in the first quarter. Wealth Alliance LLC now owns 589 shares of the company's stock valued at $363,000 after acquiring an additional 30 shares in the last quarter. Brogan Financial Inc. increased its stake in shares of Chemed by 7.3% during the first quarter. Brogan Financial Inc. now owns 426 shares of the company's stock worth $262,000 after acquiring an additional 29 shares during the period. Segall Bryant & Hamill LLC raised its holdings in Chemed by 35.6% during the first quarter. Segall Bryant & Hamill LLC now owns 32,956 shares of the company's stock worth $20,278,000 after purchasing an additional 8,645 shares in the last quarter. Finally, Lord & Richards Wealth Management LLC raised its holdings in Chemed by 109.1% during the first quarter. Lord & Richards Wealth Management LLC now owns 2,032 shares of the company's stock worth $1,250,000 after purchasing an additional 1,060 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.

Chemed Company Profile

(Get Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Articles

Insider Buying and Selling by Quarter for Chemed (NYSE:CHE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines